Literature DB >> 10218644

Antioxidant properties of melatonin: a pulse radiolysis study.

H S Mahal1, H S Sharma, T Mukherjee.   

Abstract

Various one-electron oxidants such as OH*, tert-BuO*, CCl3OO*, Br2*- and N3*, generated pulse radiolytically in aqueous solutions at pH 7, were scavenged by melatonin to form two main absorption bands with lambda(max) = 335 nm and 500 nm. The assignment of the spectra and determination of extinction coefficients of the transients have been reported. Rate constants for the formation of these species ranged from 0.6-12.5x10(9) dm3 mol(-1) s(-1). These transients decayed by second order, as observed in the case of Br2*- and N3* radical reactions. Both the NO2* and NO* radicals react with the substrate with k = 0.37x10(7) and 3x10(7) dm3 mol(-1) s(-1), respectively. At pH approximately 2.5, the protonated form of the transient is formed due to the reaction of Br2*- radical with melatonin, pKa ( MelH* <=> Mel* + H+) = 4.7+/-0.1. Reduction potential of the couple (Mel*/MelH), determined both by cyclic voltammetric and pulse-radiolytic techniques, gave a value E(1)7 = 0.95+/-0.02 V vs. NHE. Repair of guanosine radical and regeneration of melatonin radicals by ascorbate and urate ions at pH 7 have been reported. Reactions of the reducing radicals e(aq)- and H* atoms with melatonin have been shown to occur at near diffusion rates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218644     DOI: 10.1016/s0891-5849(98)00226-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  16 in total

Review 1.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 2.  Melatonin as an anti-inflammatory agent in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; A H Rezaeyan; A Salajegheh; S Rezapoor
Journal:  Inflammopharmacology       Date:  2017-03-02       Impact factor: 4.473

3.  Melatonin and steroid hormones activate intermembrane Cu,Zn-superoxide dismutase by means of mitochondrial cytochrome P450.

Authors:  Pedro Iñarrea; Alvaro Casanova; Maria Angeles Alava; María Iturralde; Enrique Cadenas
Journal:  Free Radic Biol Med       Date:  2011-03-10       Impact factor: 7.376

Review 4.  The fetal origins of the metabolic syndrome: can we intervene?

Authors:  Noelle Ma; Daniel B Hardy
Journal:  J Pregnancy       Date:  2012-09-17

5.  Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug.

Authors:  Rüdiger Hardeland; S R Pandi-Perumal
Journal:  Nutr Metab (Lond)       Date:  2005-09-10       Impact factor: 4.169

6.  Effects of adjective use of melatonin and vitamin C in the treatment of chronic periodontitis: A randomized clinical trial.

Authors:  Mohammadtaghi Chitsazi; Masoumeh Faramarzie; Mehrnoosh Sadighi; Adileh Shirmohammadi; Arash Hashemzadeh
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2017-12-13

Review 7.  Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3.

Authors:  Russel J Reiter; Dun Xian Tan; Sergio Rosales-Corral; Annia Galano; Mei-Jie Jou; Dario Acuna-Castroviejo
Journal:  Int J Mol Sci       Date:  2018-08-18       Impact factor: 5.923

8.  New evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide.

Authors:  Paolo Sarti; Maria Chiara Magnifico; Fabio Altieri; Daniela Mastronicola; Marzia Arese
Journal:  Int J Mol Sci       Date:  2013-05-28       Impact factor: 5.923

9.  Effects of melatonin on DNA damage induced by cyclophosphamide in rats.

Authors:  S G Ferreira; R A Peliciari-Garcia; S A Takahashi-Hyodo; A C Rodrigues; F G Amaral; C M Berra; S Bordin; R Curi; J Cipolla-Neto
Journal:  Braz J Med Biol Res       Date:  2013-03-08       Impact factor: 2.590

Review 10.  Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.

Authors:  Jazmin Reyes Ocampo; Rafael Lugo Huitrón; Dinora González-Esquivel; Perla Ugalde-Muñiz; Anabel Jiménez-Anguiano; Benjamín Pineda; José Pedraza-Chaverri; Camilo Ríos; Verónica Pérez de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2014-02-17       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.